H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761

Neurochem Int. 2010 Jul;56(8):893-905. doi: 10.1016/j.neuint.2010.03.016. Epub 2010 Mar 31.

Abstract

Calcium (Ca2+) dyshomeostasis may be of pivotal importance in mediating the neurotoxic action of amyloid beta peptide (Abeta), but the mechanism whereby Abeta disrupts Ca2+ homeostasis remains unclear. Using hippocampal neuronal cultures, the present study investigated possible mechanisms underlying Ca2+ dyshomeostasis induced by the oligomeric form of Abeta1-42 and two possible mediators of its toxicity, hydrogen peroxide (H2O2) and platelet-activating factor (PAF). It was found that, both H2O2 and PAF were able to reproduce each of the events induced by oligomeric Abeta1-42, including (a) Ca2+ influx via N-methyl-D-aspartic acid (NMDA) receptors, (b) enhancement of Ca2+ response to NMDA via activation of protein kinase C (PKC), (c) the increase of extracellular concentrations of glutamate and (d) the increase in cytosolic free Ca2+ ([Ca2+]i). Moreover, each of these events could be blocked by Ginkgo biloba extract EGb761, a free radical scavenger with PAF antagonism, and by quercetin, a constituent with well-established free radical scavenging property. In contrast, ginkgolide B, another constituent of EGb761 with well-established PAF-antagonizing activity protected the neurons against Ca2+ dyshomeostasis induced by Abeta1-42 and PAF, but not by H2O2. These results suggested the possibility that Abeta1-42-induced Ca2+ dyshomeostasis might be mediated by formation of toxic mediators such as H2O2 and PAF. Therefore, increased production of toxic mediators such as H2O2 and PAF in the brain may be critical in the pathological mechanism of neurodegenerative diseases, particularly Alzheimer's disease (AD), and may serve as major therapeutic targets for these diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / antagonists & inhibitors
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Calcium / antagonists & inhibitors*
  • Calcium / metabolism
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology
  • Cells, Cultured
  • Ginkgo biloba / physiology
  • Glutamic Acid / metabolism
  • Hippocampus / drug effects
  • Hippocampus / enzymology
  • Hippocampus / metabolism
  • Homeostasis / drug effects*
  • Homeostasis / physiology
  • Hydrogen Peroxide / antagonists & inhibitors
  • Hydrogen Peroxide / metabolism
  • Hydrogen Peroxide / toxicity*
  • Neurons / drug effects
  • Neurons / enzymology
  • Neurons / metabolism
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / toxicity*
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Platelet Activating Factor / antagonists & inhibitors
  • Platelet Activating Factor / metabolism
  • Platelet Activating Factor / toxicity*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Plant Extracts
  • Platelet Activating Factor
  • amyloid beta-protein (1-42)
  • Ginkgo biloba extract
  • Glutamic Acid
  • Hydrogen Peroxide
  • Calcium